Suppr超能文献

长期暴露于佛波酯后,阿尔茨海默病β淀粉样蛋白生成增加,这与蛋白激酶C的α和ε同工酶受到的不同影响相关。

Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C.

作者信息

da Cruz e Silva Odete A B, Rebelo Sandra, Vieira Sandra I, Gandy Sam, da Cruz e Silva Edgar F, Greengard Paul

机构信息

Laboratório de Neurociências, Centro de Biologia Celular, Universidade de Aveiro, Aveiro, Portugal.

出版信息

J Neurochem. 2009 Jan;108(2):319-30. doi: 10.1111/j.1471-4159.2008.05770.x. Epub 2008 Dec 2.

Abstract

Alzheimer's amyloid precursor protein (APP) sorting and processing are modulated through signal transduction mechanisms regulated by protein phosphorylation. Notably, protein kinase C (PKC) appears to be an important component in signaling pathways that control APP metabolism. PKCs exist in at least 11 conventional and unconventional isoforms, and PKCalpha and PKCepsilon isoforms have been specifically implicated in controlling the generation of soluble APP and amyloid-beta (Abeta) fragments of APP, although identification of the PKC substrate phospho-state-sensitive effector proteins remains challenging. In the current study, we present evidence that chronic application of phorbol esters to cultured cells in serum-free medium is associated with several phenomena, namely: (i) PKCalpha down-regulation; (ii) PKCepsilon up-regulation; (iii) accumulation of APP and/or APP carboxyl-terminal fragments in the trans Golgi network; (iv) disappearance of fluorescence from cytoplasmic vesicles bearing a green fluorescent protein tagged form of APP; (v) insensitivity of soluble APP release following acute additional phorbol application; and (vi) elevated cellular APP mRNA levels and holoprotein, and secreted Abeta. These data indicate that, unlike acute phorbol ester application, which is accompanied by lowered Abeta generation, chronic phorbol ester treatment causes differential regulation of PKC isozymes and increased Abeta generation. These data have implications for the design of amyloid-lowering strategies based on modulating PKC activity.

摘要

阿尔茨海默病淀粉样前体蛋白(APP)的分选和加工通过由蛋白磷酸化调节的信号转导机制进行调控。值得注意的是,蛋白激酶C(PKC)似乎是控制APP代谢的信号通路中的一个重要组成部分。PKC至少存在11种传统和非传统亚型,PKCα和PKCε亚型已被明确与控制APP可溶性片段和淀粉样β(Aβ)片段的产生有关,尽管鉴定PKC底物磷酸化状态敏感效应蛋白仍然具有挑战性。在本研究中,我们提供证据表明,在无血清培养基中对培养细胞长期应用佛波酯与几种现象相关,即:(i)PKCα下调;(ii)PKCε上调;(iii)APP和/或APP羧基末端片段在反式高尔基体网络中积累;(iv)携带绿色荧光蛋白标记形式APP的细胞质囊泡荧光消失;(v)急性额外应用佛波酯后可溶性APP释放不敏感;以及(vi)细胞APP mRNA水平、全蛋白和分泌的Aβ升高。这些数据表明,与急性应用佛波酯伴随Aβ生成降低不同,长期应用佛波酯会导致PKC同工酶的差异调节和Aβ生成增加。这些数据对基于调节PKC活性的降低淀粉样蛋白策略的设计具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e0/2911029/295da30faf9a/nihms-219961-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验